Unregistered Sales of Equity Securities and Use of Proceeds.
−Removed: On April 1, 2024, we issued 2,659,102 shares of our Class A common stock to certain sellers of Modulus Therapeutics, Inc.
−Removed: (“Modulus”), valued at approximately $3.0 million, as consideration in connection with the acquisition by merger of Modulus, in a private placement transaction exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) of the Securities Act.
−Removed: On April 26, 2024, we issued a total of 4,692,086 shares of our Class A common stock to certain former equity holders of FGen AG, valued at approximately $4.3 million, in connection with the achievement of certain milestones, in a private placement transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act.
+Added: On August 5, 2024 and September 23, 2024, we issued a total of 689,550 shares of our Class A common stock to certain former equity holders of FGen AG, valued at approximately $5.4 million, in connection with the achievement of certain milestones, in a private placement transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act.
Defaults Upon Senior Securities.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.